• Categories

  • Archives

  • Category Cloud

  • Top Clicks

Hepatitis C: Current Treatment

This page provides general information on the currently available treatment options for chronic hepatitis C. Patients with chronic hepatitis C should consult their doctors regarding possible treatment. Keep reading…

New and Future Treatments for Chronic Hepatitis C

Treatment of chronic hepatitis C is presently based on the use of interferon-alpha. Interferon-alpha is a protein that is given by injection, usually three times a week. The addition of ribivirin, a non-specific, orally administered anti-viral agent, improves the efficacy of interferon-alpha. Keep reading…

Primary Biliary Cirrhosis

World wide incidence is 4-5 / million (middle age women).
Suspected genetic component in causation (6 fold increase in frequency of DRW8 tissue type among PBC patients).
Other , such as arthritis, thyroiditis, keratoconjunctivitis, kidney and skin disease occurs with PBC.
Patients present with fatigue and itching and progresses over 10-15 years, presenting with progressive jaundice.
keep reading… 

Primary Sclerosing Cholangitis

PSC mainly affects males and is characterized by chronic inflammation of the bile ducts resulting in stricture formation and obliteration of the duct lumen. In 70% of the patients it is associated with inflammatory bowel disease (IBD). Keep reading…

Liver Diseases & Pregnancy

During pregnancy, there are significant normal physiologic changes in liver function studies. These include: Keep reading…

Liver Cancer

What is cancer of liver?
Liver Cancer Who’s at Risk?
What are the symptoms of liver cancer?
Screening for hepatocellular cancer (HCC)?
What are the diagnosis of liver cancer?
Treatment of liver cancer?
What is advanced cancer?
What is recurrent cancer?
What are side effects of treatment?
How to control the pain?
Support for people with liver cancer.

Keep reading…

Wilson’s Disease

An autosomal recessive disease of copper metabolism. The abnormal gene has been localized to chromosome 13 and is linked to enzyme esterase -D. The overall disease incidence is 1:200000. In this condition the copper excretion in the bile is reduced resulting in accumulation of copper in the liver, resulting in oxidant injury to liver cell [...]